Louis-Nicolas Veilleux1, Martin Lemay, Annie Pouliot-Laforte, Moira S Cheung, Francis H Glorieux, Frank Rauch. 1. Shriners Hospital for Children-Canada and Department of Pediatrics (L.-N.V., A.P.-L., M.S.C., F.H.G., F.R.), McGill University, Montréal, Québec, Canada; Centre de Réadaptation Marie Enfant (L.-N.V., A.P.-L.), Sainte-Justine University Hospital, Montréal, Québec, Canada; and Département de Kinanthropologie (M.L.), Université du Québec à Montréal, Montréal, Québec, Canada.
Abstract
CONTEXT: Results of previous studies suggested that children and adolescents with osteogenesis imperfecta (OI) type I have a muscle force deficit. However, muscle function has only been assessed by static isometric force tests and not in more natural conditions such as dynamic force and power tests. OBJECTIVE: The purpose of this study was to assess lower extremity dynamic muscle function and muscle anatomy in OI type I. SETTING: The study was performed in the outpatient department of a pediatric orthopedic hospital. PATIENTS AND OTHER PARTICIPANTS: A total of 54 individuals with OI type I (6-21 years; 20 male) and 54 age- and sex-matched controls took part in this study. MAIN OUTCOME MEASURES: Calf muscle cross-sectional area and density were measured by peripheral quantitative computed tomography. Lower extremity muscle function (peak force per body weight and peak power per body mass) was measured by jumping mechanography through 5 tests: multiple two-legged hopping, multiple one-legged hopping, single two-legged jump, chair-rise test, and heel-rise test. RESULTS: Compared with age- and sex-matched controls, patients with OI type I had smaller muscle size (P = .04) but normal muscle density (P = .21). They also had lower average peak force and lower specific force (peak force/muscle cross-sectional area; all P < .008). Average peak power was lower in patients with OI type I but not significantly so (all P > .054). CONCLUSIONS: Children and adolescents with OI type I have, on average, a significant force deficit in the lower limb as measured by dynamic force tests. Nonetheless, these data also show that OI type I is compatible with normal muscle performance in some individuals.
CONTEXT: Results of previous studies suggested that children and adolescents with osteogenesis imperfecta (OI) type I have a muscle force deficit. However, muscle function has only been assessed by static isometric force tests and not in more natural conditions such as dynamic force and power tests. OBJECTIVE: The purpose of this study was to assess lower extremity dynamic muscle function and muscle anatomy in OI type I. SETTING: The study was performed in the outpatient department of a pediatric orthopedic hospital. PATIENTS AND OTHER PARTICIPANTS: A total of 54 individuals with OI type I (6-21 years; 20 male) and 54 age- and sex-matched controls took part in this study. MAIN OUTCOME MEASURES: Calf muscle cross-sectional area and density were measured by peripheral quantitative computed tomography. Lower extremity muscle function (peak force per body weight and peak power per body mass) was measured by jumping mechanography through 5 tests: multiple two-legged hopping, multiple one-legged hopping, single two-legged jump, chair-rise test, and heel-rise test. RESULTS: Compared with age- and sex-matched controls, patients with OI type I had smaller muscle size (P = .04) but normal muscle density (P = .21). They also had lower average peak force and lower specific force (peak force/muscle cross-sectional area; all P < .008). Average peak power was lower in patients with OI type I but not significantly so (all P > .054). CONCLUSIONS:Children and adolescents with OI type I have, on average, a significant force deficit in the lower limb as measured by dynamic force tests. Nonetheless, these data also show that OI type I is compatible with normal muscle performance in some individuals.
Authors: A K Oestreich; S M Carleton; X Yao; B A Gentry; C E Raw; M Brown; F M Pfeiffer; Y Wang; C L Phillips Journal: Osteoporos Int Date: 2015-07-16 Impact factor: 4.507
Authors: Youngjae Jeong; Stephanie M Carleton; Bettina A Gentry; Xiaomei Yao; J Andries Ferreira; Daniel J Salamango; MaryAnn Weis; Arin K Oestreich; Ashlee M Williams; Marcus G McCray; David R Eyre; Marybeth Brown; Yong Wang; Charlotte L Phillips Journal: J Bone Miner Res Date: 2015-05-14 Impact factor: 6.741
Authors: Youngjae Jeong; Salah A Daghlas; Alp S Kahveci; Daniel Salamango; Bettina A Gentry; Marybeth Brown; R Scott Rector; R Scott Pearsall; Charlotte L Phillips Journal: Muscle Nerve Date: 2017-06-15 Impact factor: 3.217
Authors: Victoria L Gremminger; Youngjae Jeong; Rory P Cunningham; Grace M Meers; R Scott Rector; Charlotte L Phillips Journal: J Bone Miner Res Date: 2019-06-13 Impact factor: 6.741
Authors: Emily L Germain-Lee; Feng-Shu Brennen; Diana Stern; Aditi Kantipuly; Pamela Melvin; Mia S Terkowitz; Jay R Shapiro Journal: Pediatr Res Date: 2015-11-05 Impact factor: 3.756
Authors: Victoria L Gremminger; Emily N Harrelson; Tara K Crawford; Adrienne Ohler; Laura C Schulz; R Scott Rector; Charlotte L Phillips Journal: Mol Genet Metab Date: 2021-02-20 Impact factor: 4.797